bmy 7378 and sdz 216-525

bmy 7378 has been researched along with sdz 216-525 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fozard, JR; Hoyer, D; McQuade, R; Sharp, T1
Ennis, C; Khawaja, X; Minchin, MC1

Other Studies

2 other study(ies) available for bmy 7378 and sdz 216-525

ArticleYear
The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
    British journal of pharmacology, 1993, Volume: 109, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Dialysis; Electrophysiology; GTP-Binding Proteins; Hippocampus; Indoles; Male; Neurons; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Thiazoles

1993
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Life sciences, 1997, Volume: 60, Issue:9

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding, Competitive; CHO Cells; Cricetinae; Hippocampus; Humans; In Vitro Techniques; Kinetics; Piperazines; Pyridines; Radioligand Assay; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection

1997